Peter Drueckes

2.2k total citations
24 papers, 1.2k citations indexed

About

Peter Drueckes is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Peter Drueckes has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Hematology. Recurrent topics in Peter Drueckes's work include Chronic Myeloid Leukemia Treatments (5 papers), HER2/EGFR in Cancer Research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Peter Drueckes is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), HER2/EGFR in Cancer Research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Peter Drueckes collaborates with scholars based in Switzerland, Germany and United States. Peter Drueckes's co-authors include Pascal Furet, Markus Wartmann, Reinhard Schinzel, D. Palm, Christian Schnell, Vincent Bordas, Vito Guagnano, Mickaël Le Douget, Doriano Fabbro and Diana Graus Porta and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemistry.

In The Last Decade

Peter Drueckes

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Drueckes Switzerland 15 727 290 173 146 118 24 1.2k
Vito Guagnano Switzerland 16 896 1.2× 380 1.3× 343 2.0× 135 0.9× 55 0.5× 30 1.4k
Michelle L. Kraus United States 7 466 0.6× 447 1.5× 96 0.6× 124 0.8× 145 1.2× 9 1.1k
Xianping Shi China 20 683 0.9× 261 0.9× 89 0.5× 111 0.8× 154 1.3× 35 1.0k
Dario Ballinari Italy 19 608 0.8× 400 1.4× 178 1.0× 129 0.9× 53 0.4× 54 1.1k
Michael P. Sheets United States 13 584 0.8× 152 0.5× 161 0.9× 84 0.6× 69 0.6× 22 967
Gretchen M. Unger United States 17 1.2k 1.7× 438 1.5× 115 0.7× 83 0.6× 85 0.7× 29 1.6k
Giovanni Di Maira Italy 19 1.0k 1.4× 310 1.1× 114 0.7× 48 0.3× 109 0.9× 41 1.6k
Julie Litz United States 18 885 1.2× 511 1.8× 44 0.3× 144 1.0× 159 1.3× 20 1.4k
Patrick A. Plé United Kingdom 17 877 1.2× 445 1.5× 572 3.3× 169 1.2× 124 1.1× 30 1.5k
Timothy J. Guzi United States 16 792 1.1× 538 1.9× 261 1.5× 258 1.8× 47 0.4× 31 1.4k

Countries citing papers authored by Peter Drueckes

Since Specialization
Citations

This map shows the geographic impact of Peter Drueckes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Drueckes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Drueckes more than expected).

Fields of papers citing papers by Peter Drueckes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Drueckes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Drueckes. The network helps show where Peter Drueckes may publish in the future.

Co-authorship network of co-authors of Peter Drueckes

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Drueckes. A scholar is included among the top collaborators of Peter Drueckes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Drueckes. Peter Drueckes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González-Medina, Mariana, Filip Miljković, Peter Drueckes, et al.. (2019). Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitors. European Journal of Medicinal Chemistry. 187. 112004–112004. 3 indexed citations
2.
Drueckes, Peter. (2016). Protein Kinase Selectivity Profiling Using Microfluid Mobility Shift Assays. Methods in molecular biology. 1439. 143–157. 4 indexed citations
3.
Berst, Frédéric, Andreas L. Marzinzik, Henrik Moebitz, et al.. (2012). The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: A proof-of-concept study. European Journal of Medicinal Chemistry. 57. 1–9. 14 indexed citations
4.
Tiedt, Ralph, Pascal Furet, B.A. Appleton, et al.. (2011). A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients. Cancer Research. 71(15). 5255–5264. 99 indexed citations
5.
Berst, Frédéric, Andreas L. Marzinzik, Henrik Moebitz, et al.. (2011). Substrate profiling of IGF-1R and InsR: Identification of a potent pentamer substrate. Bioorganic & Medicinal Chemistry Letters. 21(23). 7030–7033. 1 indexed citations
6.
Guagnano, Vito, Diana Graus Porta, Vincent Bordas, et al.. (2011). Abstract B246: NVP-BGJ398: A potent and selective inhibitor of the fibroblast growth factor receptor family.. Molecular Cancer Therapeutics. 10(11_Supplement). B246–B246. 1 indexed citations
7.
8.
Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations
9.
Drueckes, Peter, et al.. (2010). A Fluorescence Lifetime-Based Assay for Abelson Kinase. SLAS DISCOVERY. 16(1). 65–72. 11 indexed citations
10.
Pissot‐Soldermann, Carole, Marc Gerspacher, Pascal Furet, et al.. (2010). Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2609–2613. 33 indexed citations
11.
Liniger, Marc, Christian Neuhaus, Peter Drueckes, et al.. (2010). Kinase Inhibition by Deoxy Analogues of the Resorcylic Lactone L-783277. ACS Medicinal Chemistry Letters. 2(1). 22–27. 24 indexed citations
12.
Manley, Paul W., Peter Drueckes, Gabriele Fendrich, et al.. (2009). Extended kinase profile and properties of the protein kinase inhibitor nilotinib. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1804(3). 445–453. 179 indexed citations
13.
Puttini, Miriam, Sara Redaelli, Rosalind H. Gunby, et al.. (2008). Characterization of compound 584, an Abl kinase inhibitor with lasting effects. Haematologica. 93(5). 653–661. 7 indexed citations
14.
Bettayeb, Karima, Òscar M. Tirado, Séverine Marionneau‐Lambot, et al.. (2007). Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases. Cancer Research. 67(17). 8325–8334. 95 indexed citations
15.
Li, Dongxia, Grażyna Dobrowolska, Lauri D. Aicher, et al.. (1999). Expression of the Casein Kinase 2 Subunits in Chinese Hamster Ovary and 3T3 L1 Cells Provides Information on the Role of the Enzyme in Cell Proliferation and the Cell Cycle. Journal of Biological Chemistry. 274(46). 32988–32996. 44 indexed citations
16.
Wright, James H., et al.. (1997). A role for the SHP-2 tyrosine phosphatase in nerve growth-induced PC12 cell differentiation.. Molecular Biology of the Cell. 8(8). 1575–1585. 54 indexed citations
17.
Drueckes, Peter & Reinhard Schinzel. (1996). Activation of E350A mutant maltodextrin phosphorylase by exogenously added acetate. Protein Engineering Design and Selection. 9(8). 701–705. 4 indexed citations
18.
Drueckes, Peter, et al.. (1996). Mutational Analysis of the Oligosaccharide Recognition Site at the Active Site of Escherichia coli Maltodextrin Phosphorylase. Biochemistry. 35(21). 6727–6734. 14 indexed citations
19.
Drueckes, Peter, Reinhard Schinzel, & D. Palm. (1995). Photometric Microtiter Assay of Inorganic Phosphate in the Presence of Acid-Labile Organic Phosphates. Analytical Biochemistry. 230(1). 173–177. 75 indexed citations
20.
Schinzel, Reinhard & Peter Drueckes. (1991). The phosphate recognition site of Escherichia coli maltodextrin phosphorylase. FEBS Letters. 286(1-2). 125–128. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vito Guagnano Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Xianping Shi Breakdown of academic impact, for papers by Dario Ballinari Breakdown of academic impact, for papers by Michael P. Sheets Breakdown of academic impact, for papers by Gretchen M. Unger Breakdown of academic impact, for papers by Giovanni Di Maira Breakdown of academic impact, for papers by Julie Litz Breakdown of academic impact, for papers by Patrick A. Plé Breakdown of academic impact, for papers by Timothy J. Guzi
Rankless by CCL
2026